Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "biotechnology"

394 News Found

TechInvention Lifecare breaks ground of its GCMC
Biotech | February 29, 2024

TechInvention Lifecare breaks ground of its GCMC

The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy


Biocon included in S&P Global Sustainability Yearbook 2024
Sustainability | February 20, 2024

Biocon included in S&P Global Sustainability Yearbook 2024

Sustainability is integral to Biocon's business purpose


Lupin receives approval from USFDA for Minzoya
Drug Approval | February 17, 2024

Lupin receives approval from USFDA for Minzoya

Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy


Dr. Jitendra Singh launches multi-disciplinary post-doctoral courses in Bio-Sciences
News | February 06, 2024

Dr. Jitendra Singh launches multi-disciplinary post-doctoral courses in Bio-Sciences

1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector


Thermo Fisher receives AIFA’s GMP approval for manufacturing facility of RNA-based products in Italy
News | January 22, 2024

Thermo Fisher receives AIFA’s GMP approval for manufacturing facility of RNA-based products in Italy

GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients


Novo Holdings expands portfolio in cancer diagnostics
News | January 22, 2024

Novo Holdings expands portfolio in cancer diagnostics

Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer


Lupin launches Varenicline Tablets in US
News | January 11, 2024

Lupin launches Varenicline Tablets in US

Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US


BioAsia 2024 to focus on data and AI for life sciences
News | January 11, 2024

BioAsia 2024 to focus on data and AI for life sciences

The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others


Shanghai Argo announces multi-program RNAi licenses with Novartis
News | January 11, 2024

Shanghai Argo announces multi-program RNAi licenses with Novartis

Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.